Acorda Site #223 — New York, New York

Acorda Site #223 is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Acorda Site #223 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: Acorda Therapeutics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Acorda Site #223?

Acorda Site #223 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Acorda Site #223 conducted?

Acorda Site #223 has 1 clinical trials on record. Their work covers Epilepsy.

Is Acorda Site #223 accredited by Crixeo Health?

Acorda Site #223 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Acorda Site #223?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.